Ilseong Pharmaceutical Reports Operating Loss of 1.3 Billion KRW Last Year... Turned to Deficit Compared to Previous Year

[Asia Economy Reporter Eunmo Koo] Il Sung Pharmaceutical announced on the 23rd that its operating loss turned to a deficit of 1.3 billion KRW last year compared to the previous year. During the same period, sales decreased by 21.48% to 48.4 billion KRW, while net profit increased by 83.53% to 5.4 billion KRW. The company explained, "Sales declined due to the termination of the license product contract, and net profit increased due to the rise in financial income."